Table 4.
Flow cytometry assay on 3, 7, 14, and 21 days after gamma radiation.
Markers | Days | Con | Xen | Rad | Rad + Xen |
---|---|---|---|---|---|
CD4 | 3 | 33.6 ± 4.4 | 38.6 ± 0.5 * | 14.0 ± 1.7 | 16.3 ± 1.7 # |
7 | 33.3 ± 4.2 | 32.5 ± 0.1 | 16.3 ± 1.7 | 19.2 ± 0.5 # | |
14 | 33.2 ± 4.1 | 33.2 ± 2.1 | 21.9 ± 2.2 | 28.1 ± 3.6 | |
21 | 33.3 ± 4.2 | 32.4 ± 3.8 | 28.2 ± 3.6 | 30.0 ± 2.7 | |
CD8 | 3 | 16.9 ± 1.4 | 21.3 ± 2.7 * | 11.8 ± 1.7 | 13.2 ± 1.5 # |
7 | 16.6 ± 1.3 | 18.1 ± 1.7 | 13.2 ± 1.1 | 14.2 ± 0.7 # | |
14 | 16.7 ± 1.3 | 16.1 ± 2.2 | 18.5 ± 0.1 | 15.5 ± 2.7 | |
21 | 16.6 ± 1.2 | 16.2 ± 1.9 | 19.5 ± 0.1 | 17.2 ± 2 | |
Treg | 3 | 7.7 ± 2.0 | 4.3 ± 1.2 * | 12.1 ± 1.9 | 12.0 ± 3 # |
7 | 7.8 ± 1.9 | 7.9 ± 2 | 10 ± 3.2 | 12.8 ± 1 # | |
14 | 7.6 ± 2.0 | 7.6 ± 2 | 7.9 ± 2.1 | 9.1 ± 1.2 | |
21 | 7.5 ± 2.1 | 7.5 ± 0.9 | 7.5 ± 1.1 | 8.5 ± 2 | |
CD19 | 3 | 50.9 ± 2.6 | 58 ± 5* | 45.1 ± 5.5 | 46.1 ± 2.8 # |
7 | 50.6 ± 2.4 | 54.5 ± 5 | 47.0 ± 13 | 46.2 ± 4 # | |
14 | 50.5 ± 2.5 | 50.1 ± 5 | 48.9 ± 2.0 | 46.2 ± 2.7 | |
21 | 50.6 ± 2.6 | 50.2 ± 2 | 52.3 ± 5.9 | 48.3 ± 2.5 | |
Ly6G | 3 | 6.6 ± 1 | 9.7 ± 2 * | 3.8 ± 1 | 4.2 ± 1.6 # |
7 | 6.3 ± 1 | 7.5 ± 1.4 | 5.6 ± 0.6 | 4.9 ± 0.9 # | |
14 | 6.4 ± 0.9 | 6.7 ± 1.3 | 5.9 ± 0.3 | 5.4 ± 1 | |
21 | 6.4 ± 0.8 | 6.5 ± 0.9 | 5.8 ± 0.6 | 5.2 ± 1.2 |
Con: control, Xen: cell injection group, Rad: gamma radiation group, and Xen + Rad: gamma radiation plus cell injection group.
* P ≤ 0.05 compared to the control group.
# P ≤ 0.05 compared to the Xen group.